ALDA Pharmaceuticals Corp. (APH.V)
-TSXV 0.10 0.00(0.00%) 3:56PM EDT
| Prev Close: | 0.10 |
|---|
| Open: | 0.10 |
|---|
| Bid: | 0.10 |
|---|
| Ask: | 0.14 |
|---|
| 1y Target Est: | N/A |
|---|
| Beta: | N/A |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 0.10 - 0.10 |
|---|
| 52wk Range: | 0.10 - 0.20 |
|---|
| Volume: | 67,100 |
|---|
| Avg Vol (3m): | 13,364 |
|---|
| Market Cap: | 2.16M |
|---|
| P/E (ttm): | 1.72 |
|---|
| EPS (ttm): | 0.06 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
Quotes delayed, except where indicated otherwise. Currency in CAD.
Headlines
- No Headlines available for APH.V at this time.
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 716.27 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(0-00-31)
: | N/A |
|---|
| Quarterly EPS Est
(0-00-31)
: | N/A |
|---|
| Mean Recommendation*: | N/A |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
ALDA Pharmaceuticals Corp. develops, produces, and markets infection control agent products primarily in Canada. The company offers T36, a patented infection control formulation, containing the anti-microbial ingredients, including o-phenylphenol,...
View More 
0.64%